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http://dx.doi.org/10Recessive dystrophic epidermolysis bullosa (R-DEB) is caused by mutations in the
COL7A1 gene. The most common mutation reported in Mexican families is the
c.2470insG mutation, normally detected by DNA sequencing. We report a faster and
more economical high-throughput genotyping method to detect the c.2470insG mutation
using specific TaqMan probes in a real-time polymerase chain reaction (RT-PCR) that fa-
cilitates genotype analysis with allelic discrimination plots. Our new method correctly
genotyped 45 samples that had previously been sequenced as 41 wild-type homozygous
(/), 1 heterozygous (/G) and three mutant homozygous (G/G) (100% specificity).
This new method allows high-throughput screening and furthermore is economical ($3
US/sample), fast (2 h), and sensitive as it requires only 20 ng input DNA. We used the
new test to genotype 89 individuals from 32 unrelated Mexican families with R-DEB.
The observed genotypic frequencies were 93.3% for the homozygous wild-type and
6.7% for the heterozygous genotype. The homozygous mutant genotype was not found.
In conclusion, the allelic discrimination assay by RT-PCR is a sensitive, specific and
effective high-throughput test for detecting the c.2470insG mutation.
 2014 IMSS. Published by Elsevier Inc. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Key Words: Diagnosis, Dystrophic epidermolysis bullosa, Genotyping, Real-time PCR.Introduction
Epidermolysis bullosa (EB) is an inherited disease charac-
terized by an extremely fragile skin and mucosa (1). EB pa-
tients develop blisters and sores on the skin, spontaneously
or because of minimum friction. The disease has a genetic
background and, according to its inheritance pattern, is
classified in autosomal dominant EB (D-EB) or autosomal
recessive EB (R-EB) (2,3). EB displays diversity in the
clinical phenotype, which reflects variation in the genes
affected (4). Three mayor subtypes have been described:tributed equally to this work.
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.1016/j.arcmed.2014.09.003EB simplex, junctional EB, and dystrophic EB (DEB)
(1,5,6). In EB simplex, the genes encoding keratin 5 and
14 are affected (2), whereas in junctional EB the genes lam-
inin alpha 3 and laminin 5 have alterations (2). DEB is
caused by mutations in the type VII collagen gene
(COL7A1). Type VII collagen is an essential component
of the anchoring fibrils in the sublamina densa of the
dermal-epidermal junction (7).
Both dominant DEB (D-DEB) and recessive DEB (R-
DEB) present mutations in the gene COL7A1 (8). R-DEB
is one of the most severe forms of EB characterized by le-
sions covering large areas of the body, which may eventu-
ally mutilate limbs (6,9). Hundreds of COL7A1 mutations
have been reported and there is a genotype-phenotype cor-
relation as the severity of the disease depends on the type
and location of the mutation. Genetic abnormalities suchcess article under the CC BY-NC-ND license (http://creativecommons.org/
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the COL7A1 cause severe disease (7,9). The c.2470insG
mutation (a guanine insertion) in exon 19 generates a
PTC downstream in exon 20 of the COL7A1 gene (8,10).
This alteration has been reported to be the most frequent
in Hispanic Mexican R-DEB patients (58%) (6,8e10).
Actually, the standard method to detect mutations in mono-
genetic disorders is nucleotide sequencing, and this tech-
nique has been applied to detect the c.2470insG mutation
in exon 19 of the COL7A1 gene (6,8,9,11). However, this
method is relatively expensive and time-consuming, espe-
cially for a large number of samples (12).
The principal aim of this work was to develop a faster
and more economical method that allows high-throughput
detection of the c.2470insG mutation in the COL7A1 gene.
Once the new method was validated, it was used to deter-
mine the allelic and genotypic frequencies in unrelated
Mexican families with R-DEB.Materials and Methods
Primers-Probe Design
To detect the 2470insG mutation, we designed a real-time
allelic discrimination assay using customized primers and
probes for a selected region of theCOL7A1 gene, which were
purchased fromApplied Biosystems (Foster City, CA) under
the concept of Assay by Design Genotyping Taqman
Assays. Our real-time allelic discrimination method used
two allele-specific labeled probes, one to detect the wild-
type allele () and the other to detect the mutant allele with
the guanine nucleotide insertion. The genotype analysis was
performed according to the manufacturer’s instructions.
The sensitivity and specificity of our real-time allelic
discrimination assay were tested on 45 DNA samples that
had been genotyped previously by nucleotide sequencing (8).
Subjects
After having validated our genotypingmethod, it was used to
determine the c.2470insG mutation frequency in Mexican
families. A total of 89 individuals from 32 unrelatedMexican
families with R-DEB of the central and northern part of
Mexico were recruited for this study through the DebRA
Mexico A.C. foundation. This protocol was approved by
the Research and Ethics Committees of the University of
Monterrey (registration number: 132012-CIE). After having
obtained informed consent, 5-mL peripheral blood samples
were collected in K2 EDTA-containing vacutainers (BD Di-
agnostics, Franklin Lakes, NJ). Genomic DNAwas extracted
fromwhite blood cells using theWizardGenomicDNAPu-
rification Kit (Promega, Madison, WI). DNA samples were
stored in cryovials at 20C until analysis.
Allele and genotype frequencies were calculated using
SPSS v.20 (IBM Corp., Armonk, NY). Allele and genotype
frequencies were calculated for a) the studied population asa whole, b) the R-DEB patient group, and c) 13 selected
families in which, apart from the patient, both parents could
be genotyped.Results
RT-PCR Validation
We improved the detection efficiency of the c.2470insG
mutation by being able to screen 96 samples in 2 h with
100% sensitivity and specificity. Forty-five samples of R-
DEB patients and their relatives that had been genotyped
previously by DNA sequencing and included representa-
tives of all genotype options (/,/G, and G/G) (6) were
genotyped identically by our real-time allelic discrimina-
tion method (Figure 1).
c.2470insG Frequency in Families with R-DEB
The 89 subjects who participated in this study come from 32
unrelatedMexican families inwhich at least onemember suf-
fered fromR-DEB. Therewere 39 (40%)R-DEB patients (36
children, two fathers and onemother) and 50 healthy individ-
uals (24 mothers, 18 fathers, and eight siblings).
In the studied population of 89 subjects, the G allele was
contributed only by heterozygous genotypes. The frequency
of the G allelewas 3.4%. The observed genotype frequencies
were 93.3% for the homozygous wild-type (/) and 6.7%
for the heterozygous genotype (/G). The homozygous
mutant genotype (G/G) was not found (Table 1).
Among subjects suffering from R-DEB (n 5 39), the
mutant G allele frequency was 3.8%; a 0.4% increase as
compared to the studied population (n 5 89). The genotype
frequencies among patients suffering R-DEB were 92.3%
for the / and 7.7% for /G genotypes, respectively
(Table 1).
The genotype distribution in the 13 selected families was
as follows: the homozygous wild-type (/) was found in
13 healthy mothers, 11 healthy fathers and 16 offspring, of
which three were healthy but 13 were affected. The hetero-
zygous genotype (/G) corresponded to two healthy fathers
and four offspring, of which three were affected and one
was healthy.Discussion
The nucleotide sequencing method is considered a gold stan-
dard for mutation detection (11). However, its low sensitivity
may lead to inadequate analysis and false negatives in sam-
ples with a low DNA concentration (13). Furthermore,
sequencing is more laborious, time-consuming, and expen-
sive as compared to real-time PCR genotyping (12).
We succeeded in developing a real-time PCR genotyping
assay that detects the c.2470insG mutation with a 100%
concordance as compared to the standard method of
Figure 1. Genotyping results by the new RT-PCR method. Genotype classification of the c.2470insG mutation is shown in the allelic discrimination plot. Red
dots represent the homozygous wild-type (/); green dots represent the heterozygous genotype (/G), and blue dots represent the homozygous mutant (G/
G). The latter were controls that did not form part of the population studied.
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genotyping assay are that a) less input DNA input is
required (20 ng), b) high-throughput option facilitates the
parallel analysis of a large number of patient samples
(96), c) results are obtained rapidly (2 h), d) analysis is
simplified as genotypes can be read from allelic discrimina-
tion plots (Figure 1), and e) low cost per test ($3 US).
The allele frequency of the c.2470insGmutation in our R-
DEB population in the current study (3.4%) is low comparedto previous reports from Salas-Alanis et al. in which this fre-
quency in an R-DEB population was O51% (6,10). The
discrepancy can be explained by a different constitution of
patient populations. The current study involved patients from
32 unrelated families, whereas the 21 families studied by
Salas-Alanis et al. included 12 families inwhich themutation
had been propagated from a common ancestral allele (6,10).
Alternatively, there could be a founder effect in the Salas-
Alanis study (6,10). Founder populations are characterized
Table 1. Genotype frequencies in 89 subjects of 32 unrelated Mexican families in which at least one member experienced R-DEB
Genotypes in all subjects Genotypes in healthy Genotypes in patients
Genotypes n Frequency (%) Genotypes n Frequency (%) Genotypes n Frequency (%)
/ 83 93.3 / 47 94 / 36 92.3
G/ 6 6.7 G/ 3 6 G/ 3 7.7
G/G 0 0.0 G/G 0 0.0 G/G 0 0.0
599Detecting 2470insG Mutation by RT-PCRby low genetic variation, which facilitates the detection of
mutations that are rare in the general population (14). When
screening the 1000 Genomes Project database for SNPs re-
ported at the location of the c.2470insG mutation (also
known as c.2471dupG), chr3:48626191-48626191 (based
onHomo sapiens annotation release 105), no datawere found
(15). This suggests that either the frequency of c2470insG is
extremely low in the general population or its occurrence is
endemic. Either way, larger cohorts from a larger geograph-
ical area should be studied to elucidate c.2470insG fre-
quency. The presence of healthy individuals with a
heterozygous phenotype in our population (Table 1) corrob-
orates that c.2470insG is a recessive allele. R-DEB patients
heterozygous for c.2470insG or homozygous for the wild-
type probably have another or an additional mutant locus that
is responsible for disease. Consequently, a heterozygous
phenotype for c.2470insG is not sufficient for R-DEB
screening.
In conclusion, the allelic discrimination assay by
RT-PCR genotyping is a sensitive, specific and effective
methodology for detecting the c.2470insG mutation. Larger
cohorts should be screened to determine the frequency of
the c.2470insG mutation in R-DEB patients.Acknowledgments
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